Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen‐deprivation therapy

S. Basaria,D. Muller,M. Carducci,J. Egan,A. Dobs
DOI: https://doi.org/10.1002/cncr.21642
IF: 6.9209
2006-02-01
Cancer
Abstract:Prostate carcinoma (PCa) is one of the most common malignancies in men. Androgen‐deprivation therapy (ADT) is used frequently in the treatment of recurrent and metastatic PCa, rendering these men hypogonadal. Because male hypogonadism is associated with an unfavorable metabolic profile, and men with PCa have high cardiovascular mortality, the authors evaluated the effects of long‐term ADT on fasting glucose levels, insulin levels, and insulin resistance.
What problem does this paper attempt to address?